Vivo Opportunity Fund Holdings, L.P.'s Net Worth
$582 Million
Who is Vivo Opportunity Fund Holdings, L.P.?
Vivo Opportunity Fund Holdings, L.P. has an estimated net worth of $582 Million. This is based on reported shares across multiple companies, which include SOLENO THERAPEUTICS INC, Terns Pharmaceuticals, Inc., Sierra Oncology, Inc., IO Biotech, Inc., and Bolt Biotherapeutics, Inc..
SEC CIK
Vivo Opportunity Fund Holdings, L.P.'s CIK is 0001930214
Past Insider Trading and Trends
2022 was Vivo Opportunity Fund Holdings, L.P.'s most active year for acquiring shares with 6 total transactions. Vivo Opportunity Fund Holdings, L.P.'s most active month to acquire stocks was the month of July. 2023 was Vivo Opportunity Fund Holdings, L.P.'s most active year for disposing of shares, totalling 14 transactions. Vivo Opportunity Fund Holdings, L.P.'s most active month to dispose stocks was the month of October. 2023 saw Vivo Opportunity Fund Holdings, L.P. paying a total of $25,037,648.10 for 14,733,881 shares, this is the most they've acquired in one year. In 2022 Vivo Opportunity Fund Holdings, L.P. cashed out on 5,185,385 shares for a total of $183,123,160.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $45.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +162.81% | 5.21M |
$2.50 | $13,037,500.00 | 8.42M |
Oct 2
| |||
Form 4
|
∞
| 3.2M |
$1.75 | $5,605,412.75 | 3.2M |
Sep 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $5.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.32% | -420.66K |
$6.65 | -$2,796,859.03 | 6.24M |
Scheduled
|
Apr 1 - Apr 3
| ||
Form 4
| +21.18% | 758.62K |
$7.25 | $5,499,995.00 | 4.34M |
Dec 23
| |||
Form 4
| +20.12% | 600K |
$3.60 | $2,160,000.00 | 3.58M |
Sep 7
| |||
Form 4
| +142.80% | 2.62M |
$2.70 | $6,980,244.40 | 4.46M |
Aug 12 - Aug 16
| |||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.33M |
$55.00 | -$183,123,160.00 |
0
|
Jul 1
| |||
| No matching records found | |||||||||
IO Biotech, Inc. (IOBT) Snapshot price: $1.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.16M |
$1.90 | $5,999,998.60 | 3.16M |
Aug 9
| |||
| No matching records found | |||||||||
Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $1.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.15% | -3.40K |
$0.90 | -$3,060.00 | 2.33M |
Nov 21
| |||
Form 4
| -1.35% | -86.05K |
$0.93 | -$79,933.22 | 6.31M |
Nov 16 - Nov 20
| |||
| No matching records found | |||||||||